Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.

In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity.

Patel J, Buddha B, Dey S, Pal D, Mitra AK.

Am J Ther. 2004 Jul-Aug;11(4):262-77.

PMID:
15266218
2.

MDR- and CYP3A4-mediated drug-herbal interactions.

Pal D, Mitra AK.

Life Sci. 2006 Mar 27;78(18):2131-45. Epub 2006 Jan 25. Review.

PMID:
16442130
3.

Herbal modulation of P-glycoprotein.

Zhou S, Lim LY, Chowbay B.

Drug Metab Rev. 2004 Feb;36(1):57-104. Review.

PMID:
15072439
4.

MDR- and CYP3A4-mediated drug-drug interactions.

Pal D, Mitra AK.

J Neuroimmune Pharmacol. 2006 Sep;1(3):323-39. Epub 2006 Aug 2. Review.

PMID:
18040809
5.

Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.

Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL.

Clin Pharmacokinet. 2005;44(3):279-304. Review.

PMID:
15762770
6.

New insights into drug absorption: studies with sirolimus.

Paine MF, Leung LY, Watkins PB.

Ther Drug Monit. 2004 Oct;26(5):463-7. Review.

PMID:
15385826
7.

Unmasking the dynamic interplay between efflux transporters and metabolic enzymes.

Benet LZ, Cummins CL, Wu CY.

Int J Pharm. 2004 Jun 11;277(1-2):3-9. Review.

PMID:
15158963
8.

Pharmacokinetic interactions between herbal remedies and medicinal drugs.

Ioannides C.

Xenobiotica. 2002 Jun;32(6):451-78. Review.

PMID:
12160480
9.

Transporter-enzyme interactions: implications for predicting drug-drug interactions from in vitro data.

Benet LZ, Cummins CL, Wu CY.

Curr Drug Metab. 2003 Oct;4(5):393-8. Review.

PMID:
14529371
10.

Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.

Goey AK, Mooiman KD, Beijnen JH, Schellens JH, Meijerman I.

Cancer Treat Rev. 2013 Nov;39(7):773-83. doi: 10.1016/j.ctrv.2012.12.008. Epub 2013 Feb 8. Review.

PMID:
23394826
11.
12.

Interactions of herbs with cytochrome P450.

Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW.

Drug Metab Rev. 2003 Feb;35(1):35-98. Review.

PMID:
12635815
13.

The role of pharmacological enhancement in protease inhibitor-based highly active antiretroviral therapy.

Becker SL.

Expert Opin Investig Drugs. 2003 Mar;12(3):401-12. Review.

PMID:
12605563
14.

Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines.

Müller AC, Kanfer I.

Biopharm Drug Dispos. 2011 Nov;32(8):458-70. doi: 10.1002/bdd.775. Review.

PMID:
22024968
15.
16.
17.

P-Glycoprotein- and cytochrome P-450-mediated herbal drug interactions.

Kumar YS, Adukondalu D, Sathish D, Vishnu YV, Ramesh G, Latha AB, Reddy PC, Sarangapani M, Rao YM.

Drug Metabol Drug Interact. 2010;25(1-4):3-16. doi: 10.1515/DMDI.2010.006. Review.

PMID:
21417789
18.

[Pharmacological interactions with darunavir].

Moltó J, Valle M, Clotet B.

Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:43-50. Review. Spanish.

PMID:
19195459
19.

Evaluation of metabolism-mediated herb-drug interactions.

Na DH, Ji HY, Park EJ, Kim MS, Liu KH, Lee HS.

Arch Pharm Res. 2011 Nov;34(11):1829-42. doi: 10.1007/s12272-011-1105-0. Epub 2011 Dec 3. Review.

PMID:
22139684
20.

Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine.

Suzuki H, Sugiyama Y.

Eur J Pharm Sci. 2000 Nov;12(1):3-12. Review.

PMID:
11121729

Supplemental Content

Support Center